The University of Chicago Header Logo

Connection

Robert Wollmann to Motor Endplate

This is a "connection" page, showing publications Robert Wollmann has written about Motor Endplate.
Connection Strength

0.357
  1. Synaptic basal lamina-associated congenital myasthenic syndromes. Ann N Y Acad Sci. 2012 Dec; 1275:36-48.
    View in: PubMed
    Score: 0.108
  2. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane. J Immunol. 1987 May 15; 138(10):3269-75.
    View in: PubMed
    Score: 0.074
  3. Focal caspase activation underlies the endplate myopathy in slow-channel syndrome. Ann Neurol. 2004 Mar; 55(3):347-52.
    View in: PubMed
    Score: 0.059
  4. Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome. Ann N Y Acad Sci. 1998 May 13; 841:167-80.
    View in: PubMed
    Score: 0.039
  5. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology. 2003 Dec 23; 61(12):1743-8.
    View in: PubMed
    Score: 0.015
  6. Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome. J Neurosci. 2002 Aug 01; 22(15):6447-57.
    View in: PubMed
    Score: 0.013
  7. Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents. Synapse. 1997 Dec; 27(4):367-77.
    View in: PubMed
    Score: 0.010
  8. Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic study. Muscle Nerve. 1997 Oct; 20(10):1284-95.
    View in: PubMed
    Score: 0.009
  9. A transgenic mouse model of the slow-channel syndrome. Muscle Nerve. 1996 Jan; 19(1):79-87.
    View in: PubMed
    Score: 0.008
  10. Function and ultrastructure of the neuromuscular junction in post-polio syndrome. Ann N Y Acad Sci. 1995 May 25; 753:129-37.
    View in: PubMed
    Score: 0.008
  11. The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravis. Ann Neurol. 1993 Jul; 34(1):48-56.
    View in: PubMed
    Score: 0.007
  12. The beta 2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG). Int J Immunopharmacol. 1993 Jan; 15(1):19-24.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.